Showing results (11-20 of 236) with videos related to
Sort By:
Pageof 24
Diabetes|September 10, 2010
Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetesCecilia Morgantini, Satoshi Imaizumi, Victor Grijalva, et al.Seminars in Cancer Biology|November 14, 2020
Apolipoprotein mimetics in cancerSamuel C Delk, Arnab Chattopadhyay, Joan Carles Escola-Gil, et al.Journal of Lipid Research|October 29, 2008
The role of dysfunctional HDL in atherosclerosisMohamad Navab, Srinivasa T Reddy, Brian J Van Lenten, et al.Current Drug Targets|March 14, 2008
Apo A-1 mimetic peptides as atheroprotective agents in murine modelsMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.Journal of Lipid Research|March 30, 2011
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orallyMohamad Navab, Srinivasa T Reddy, G M Anantharamaiah, et al.Lipids in Health and Disease|July 10, 2012
Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activityTheodoros Kelesidis, Srinivasa T Reddy, Diana Huynh, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 18, 2009
Structure and function of HDL mimeticsMohamad Navab, Ishaiahu Shechter, G M Anantharamaiah, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2016
Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage FunctionNiyati U Mehta, Victor Grijalva, Susan Hama, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 10, 2004
Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse modelsSrinivasa T Reddy, Julie T Nguyen, Victor Grijalva, et al.Diabetes|August 20, 2011
Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetesCecilia Morgantini, Andrea Natali, Beatrice Boldrini, et al.Pageof 24